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Stimulating discussions with S. Kivelson, A. Huxley, and D. Agterberg; sample characterization by K. Avers (Northwestern); and instrument design assistance from G. Burkhard (Stanford) are greatly appreciated. This work was supported by the U.S. Department 3 Clive L. Metcalfe, 3 Emma J. Murphy, 3 Jaswir Basran, 1 Maria Grazia Concilio, 4 Susana C. M. Teixeira, 2, 5 Tobias E. Schrader, 6 Alistair J. Fielding, 4 Andreas Ostermann, 7 A erobic organisms have evolved to use the intrinsic oxidizing power of oxygen from the atmosphere. This activation of oxygen is achieved by a catalytic metal center (usually iron or copper) buried within a protein. In the case of iron, high-valent iron-oxo (also known as ferryl) intermediates play a role in a large number of different, and sometimes difficult, biological oxidations catalyzed by various heme and non-heme iron-containing enzymes.
For the heme iron enzymes, the mechanism of oxidation involves initial formation of the iconic compound I intermediate (1, 2) . Compound I contains an oxidized ferryl heme, plus either a porphyrin p-cation radical or a protein radical; reduction of compound I by one electron yields the closely related compound II intermediate, which contains only the ferryl heme. These compound I and II intermediates are a defining feature across the heme enzyme family and appear in a diverse group of catalytic heme enzymes that include all the cytochrome P450s, the nitric oxide synthases, and the terminal oxidases, plus the heme dioxygenases and heme peroxidases. Indeed, they are such crucial intermediates in so many processes-including many involved in drug metabolism and other important oxidations-that their structure and reactivity has become a key question for both heme (3) (4) (5) (6) (7) and non heme iron enzymes where similarly transient iron-oxo species are also employed (8, 9) .
A long-standing and highly contentious question has been to clarify the bond order and protonation state of the ferryl heme. The question has focused on whether the ferryl is formulated as an Fe(IV)=O [iron(IV)-oxo] or Fe(IV)-OH [iron(IV)-hydroxide] species, but there are a number of reasons why previous methodologiesnone of which can measure the protonation state directly-have failed to fully resolve the issue. To begin with, even capturing these transient intermediates in some enzymes [especially in the P450s (10, 11) ] has proved very difficult. Early approaches to the problem used both extended x-ray absorption fine structure and resonance Raman methods [reviewed in (12) ] to examine the iron-oxygen bond as an indirect reporter on the protonation state. These studies indicate a short Fe-O bond length, but the data were not totally consistent, and the photolability of compound I during laser excitation is well documented (13) so that interpretation of stretching frequencies from Raman work has not been unambiguous either. More recently, x-ray crystallographic methods have been employed. These methods showed longer iron-oxygen bond lengths, but the x-ray structures of compounds I and II were subsequently shown to have been affected by photoreduction of the iron and are now considered to be unreliable. The more recent use of multiple crystals in x-ray analyses minimizes photoreduction but cannot entirely eliminate the problem. Moreover, hydrogen atoms are difficult to locate in electron density maps due to their weak scattering. Even if very highresolution data (i.e., better than 1.2 Å) are available, hydrogen atoms can remain obscured due to their mobility. There is also the substantive question of whether such small changes in Fe-O bond length (<0.2 Å) between Fe(IV)=O and Fe (IV)-OH species, even if measured at high resolution and without photoreduction, are determined accurately enough in x-ray experiments to report reliably on the protonation state.
For these reasons, we have adopted a different approach. Neutron diffraction offers a more reliable solution to the problem, because hydrogen and, particularly, its isotope deuterium (D) are visible at much lower resolutions than required with x-rays (14, 15) . The approach does present a number of challenges, particularly the need to cool the large crystals required for neutron crystallography down to the cryogenic temperatures required for the study of enzyme intermediates (16) . But the fact that neutrons are non-ionizing and are scattered by the atomic nuclei (rather than by the electrons, as in x-ray crystallography) means that photoreduction, which has been the source of most of the confusion in previous x-ray work, does not occur at all. In the case of redox enzymes, the elimination of photoreduction is a considerable advantage if the other experimental challenges can be overcome.
In this work, we have used neutron crystallography to determine the structure of ferric cytochrome c peroxidase (CcP) and its transient ferryl intermediate. The structures allow us to visualize the positions of hydrogen and deuterium atoms in the enzyme, as well as to unambiguously identify the protonation state of the ferryl heme. Cytochrome c peroxidase catalyzes the H 2 O 2 -dependent oxidation of cytochrome c. Compound I of CcP, formed rapidly from the reaction of ferric enzyme with peroxide, contains a ferryl heme plus a stable protein radical on Trp 191 (17) . It was the first peroxidase to be crystallized (18) and over many years has served as a model enzyme for the understanding of oxygen activation across the family of catalytic heme enzymes. We first solved the neutron structure of ferric CcP to 2.4 Å at room temperature. The structure was determined using x-ray and neutron diffraction data obtained from a D 2 O-exchanged crystal (see supplementary materials and methods; data and refinement statistics are shown in table S1). Figure 1 shows nuclear scattering and electron density of ferric CcP in the region of the heme and summarizes the positions of all the hydrogen and deuterium atoms. On the distal side of the heme (Fig. 1, A and C In the neutron experiment, neutrons are diffracted by the atomic nuclei (in contrast to x-rays, which are scattered by electrons). Hydrogen atoms (shown in magenta) have a negative coherent neutron scattering length (-3.74 fm), whereas deuterium atoms (shown in white) have a positive coherent scattering length (6.77 fm). Exchangeable hydrogen atoms, therefore, show up with density similar to carbon (6.65 fm) and oxygen (5.85 fm), whereas nitrogen has a greater scattering length (9.37 fm).The scatter from a methylene (CH 2 ) group sums to nearly zero, so that at moderate resolution (~2 to 2.5 Å) cancellation of nuclear scattering density is observed, and the joint refinement allows use of the x-ray terms to place the nonhydrogen atoms in these regions. Nuclear scattering density [sA-weighted 2F o -F c contoured at 2.6 root mean square (RMS)] in the (A) distal and (B) proximal heme pocket is shown in cyan. Electron density (sAweighted 2F o -F c contoured at 2.4 RMS) in the (C) distal and (D) proximal pocket is shown in magenta. The black contour (sA-weighted neutron F o -F c contoured at 5.0s) shows the difference density calculated by omitting the bound water (W1). Protonation states are depicted for (E) distal and (F) proximal active site residues. The distal pocket shows an ordered water molecule (W1) 2.7 Å away from the five-coordinate heme iron. W1 donates a hydrogen bond to the p orbitals of the porphyrin ring and may be a potential hydrogen bond acceptor to the deuterated N e of Trp 51 . W1 may also interact with a poorly ordered water (not shown) that displaces the guanidinium of Arg 48 , which is seen in the "out" position (19 with hydrogen peroxide as previously reported (19) . Formation of compound I in CcP crystals is established [e.g., (20, 21) ] but was verified in several ways. Single-crystal microspectrophotometry at 100 K on similar (smaller) crystals showed the characteristic absorption peaks in the visible region (530, 560, and 632 nm) ( fig. S1A ), in agreement with the literature (22) . Spectra of these crystals were unchanged on storage over 20 days (fig. S1B ). Single-crystal electron paramagnetic resonance (EPR) on similar crystals prepared and reacted in the same way (see supplementary materials and methods) also showed the appearance of the characteristic g = 2 signal from the Trp 191 radical (17) (fig. S2 ); in solution, compound I of CcP is stable for hours at room temperature (23) and indefinitely at 77 K (figs. S3 and S4).
We then used x-ray and neutron diffraction data to determine the 2.5 Å resolution neutron structure of compound I of CcP at 100 K (see supplementary materials and methods). Figure  2 shows nuclear scattering and electron density in the region of the heme and summarizes the positions of all the hydrogen and deuterium atoms. Data and refinement statistics are shown in table S2. Nuclear scattering and electron density maps for individual active site residues are shown in fig. S5 . In comparison to the ferric enzyme, most of the protonation states are retained in the compound I structure, with the exception of His 52 , which is now deuterated at both N d and N e (fig. S5D ). We observe that the N e of the Trp 191 radical is deuterated, which identifies the radical species as a (protonated) p-cation radical (24) . Compared to the ferric enzyme, Arg 48 has moved into the heme pocket.
Analysis of the nuclear scattering density maps indicates that the ferryl oxygen is not deuterated in the structure. This is confirmed by examination of the hydrogen bond structure: The ferryl oxygen acts as a hydrogen bond acceptor to the N e of Trp 51 and to the N e of Arg
48
, both of which are accordingly deuterated. We interpret this geometry as consistent with an unprotonated Fe(IV)=O species. An F o -F c neutron map calculated in the absence of the ferryl oxygen shows a peak (3.8s) in nuclear scattering density at 1.6 Å from the iron atom (Fig. 2, A and B) , which is consistent with the most recent x-ray data [reported as 1.63 Å (19) and 1.73 Å (25)]. However, bond lengths cannot be determined precisely at this resolution and, as we note above, report only indirectly on the protonation state. The unambiguous observation from the neutron structure is that the oxygen is not protonated, which establishes that the ferryl intermediate is an Fe(IV)=O species at this pH. The neutron data show that there is no hydrogen bond from the distal histidine to the ferryl heme, as has been suggested previously (26) in horseradish peroxidase to account for pH-dependent spectroscopic behavior of the ferryl intermediate.
Mechanisms for O-O bond cleavage in peroxidases are invariably drawn (1, 27) showing the distal histidine (His 52 in the case of CcP) as neutral in both ferric and compound I species, which assumes that both protons of H 2 O 2 are used in the formation of a water molecule. Our data are not consistent with this long-standing description. His 52 is indeed neutral in the ferric state ( Fig. 1 and fig. S5E ) but is deuterated on N e and N d in compound I (Fig. 2 and fig. S5D ). We take this to mean that the widely assumed role of the distal histidine in compound I formationacting first as a base catalyst (to deprotonate peroxide) and then as an acid catalyst (to protonate the peroxide oxygen and release water)-needs to be reassessed.
Possible and N e , the latter acting as a hydrogen bond donor to a bound water molecule (W2). W2 donates a hydrogen bond to the p orbitals of the porphyrin ring. Color scheme is as in Fig. 1 , with the iron and ferryl oxygen depicted as orange and red spheres.
not interact ideally with any neighboring proton donors. This lack of ideal hydrogen bonding structure in the ferric form may favor formation of the peroxide complex and the deprotonated compound 0 (28), as structures of the closely related compound III (oxy) complexes all suggest that more favorable hydrogen bonding interactions with the bound peroxide are likely ( fig. S6 ). Our data suggest that His 52 retains a proton upon formation of compound I. In terms of proton count, this presumably means that delivery of an additional proton to compound 0 is needed for compound I formation if water is released as product (Fig. 3A) , aligning the mechanism more closely with the related P450s in which delivery of a single proton to compound 0 is also widely assumed (2, 29) . Arg 48 , which is protonated ( Figs. 1 and 2) , could act as the source of the additional proton required for release of water in both formation and reduction of compound I, as it is thought to play a role in protonrelay networks (30) . Hydroxide (instead of water, Fig. 3A ) formation is also possible; if this is the case, a role for Arg 48 in charge stabilization of OH -is easily envisaged and would be consistent with early predictions (31) . Because the proton on His 52 must be removed before a second turnover of the enzyme can occur, the acid-catalysis role of His 52 must occur after compound I formation and not [as is often assumed (1)] before (Fig. 3A ). An alternative and intriguing possibility (Fig. 3B) , which could apply generally to any heme protein with a distal histidine in the heme pocket, is that O-O bond cleavage initially forms a transient Fe(IV)-OH species [as in the P450s (32) ], but the presence of the distal histidine provides an escape route for the proton, thus disfavoring formation of Fe(IV)-OH. Proton transfer in this direction, to form Fe(IV)=O, would be consistent with published pK a s (K a , acid dissociation constant) for the distal histidine across the peroxidase family [estimated pK a ≈ 4 to 5 (1, 33) ] if the pK a of the ferryl heme, which is not known reliably for a heme peroxidase, was lower than that. 
